Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2386 USD | -4.25% |
|
-4.18% | -58.50% |
20/06 | Maxim Initiates Virios Therapeutics at Buy Rating With $1 Price Target | MT |
20/05 | Top Midday Decliners | MT |
Chart calendar Virios Therapeutics, Inc.
Upcoming events on Virios Therapeutics, Inc.
Past events on Virios Therapeutics, Inc.
18/06/2024 08:30 pm | Annual General Meeting |
09/05/2024 06:00 pm | Q1 2024 Earnings Call |
09/05/2024 05:15 pm | Q1 2024 Earnings Release |
01/03/2024 09:30 pm | Extraordinary Shareholders Meeting |
29/02/2024 07:45 pm | Q4 2023 Earnings Release |
13/11/2023 07:00 pm | Q3 2023 Earnings Call |
13/11/2023 05:35 pm | Q3 2023 Earnings Release |
19/10/2023 08:30 pm | ThinkEquity Conference |
18/09/2023 08:30 pm | Business Update Call |
10/08/2023 06:00 pm | Q2 2023 Earnings Call |
10/08/2023 04:35 pm | Q2 2023 Earnings Release |
15/06/2023 08:30 pm | Annual General Meeting |
11/05/2023 04:35 pm | Q1 2023 Earnings Release |
14/03/2023 04:35 pm | Q4 2022 Earnings Release |
07/12/2022 08:30 pm | Planet MicroCap Showcase |
14/11/2022 07:00 pm | Q3 2022 Earnings Call |
14/11/2022 05:35 pm | Q3 2022 Earnings Release |
19/09/2022 06:00 pm | IMC-1 Phase 2b Study Results Call |
17/08/2022 07:45 pm | Q3 Investor Summit |
11/08/2022 06:00 pm | Interim 2022 Earnings Call |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
EBIT Million USD | Released Forecast Spread | 0,00 | -15,6 -17,2 8.99% | -12,3 -13,1 5.8% | -5,45 -6,06 10.05% | -5,76 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -16,0 -17,1 6.67% | -12,2 -13,1 6.24% | -5,30 -5,95 10.95% | -5,61 |
Net income Million USD | Released Forecast Spread | -10,3 | -16,0 -18,4 13.26% | -12,2 -13,1 6.24% | -5,30 -5,95 10.95% | -5,71 |
EPS USD | Released Forecast Spread | -2,10 | -1,92 -2,21 13.12% | -1,11 -1,18 5.93% | -0,28 -0,32 11.11% | -0,25 |
Announcement Date | 18/03/21 | 17/03/22 | 14/03/23 | 29/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBIT Million USD | Released Forecast Spread | -3,96 -4,32 8.37% | -3,67 -4,21 12.69% | -2,59 -4,08 36.43% | -2,09 -2,86 26.96% | -1,56 -3,70 57.91% | -1,48 -1,70 13.1% | -1,27 -1,81 29.71% | -1,14 -1,75 35% | -1,36 | -1,46 | -1,51 | |||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,96 -4,49 11.7% | -3,67 -4,21 12.81% | -2,58 -4,08 36.84% | -2,04 -2,86 28.54% | -1,52 -3,70 59% | -1,44 -1,70 15.24% | -1,24 -1,81 31.88% | -1,10 -1,75 37% | -1,31 | -1,47 | -1,53 | |||
Net income Million USD | Released Forecast Spread | -3,96 -4,49 11.7% | -3,67 -4,21 12.81% | -2,58 -4,08 36.84% | -2,04 -2,86 28.54% | -1,52 -3,70 59% | -1,44 -1,70 15.24% | -1,24 -1,81 31.88% | -1,10 -1,75 37% | -1,33 | -1,46 | -1,51 | |||
EPS USD | Released Forecast Spread | -0,48 -0,54 10.28% | -0,44 -0,51 12.87% | -0,28 -0,49 42.86% | -0,11 -0,16 29.03% | -0,08 -0,20 60% | -0,08 -0,09 11.11% | -0,06 -0,10 36.84% | -0,06 -0,09 33.33% | -0,07 -0,04 -75% | -0,06 | -0,06 | -0,06 | -0,05 | -0,05 |
Announcement Date | 12/05/22 | 11/08/22 | 14/11/22 | 14/03/23 | 12/05/23 | 10/08/23 | 13/11/23 | 29/02/24 | 09/05/24 | - | - | - | - | - |
Past sector events for Virios Therapeutics, Inc.
05/06/2024 01:21 pm | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
17/05/2024 04:30 pm | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
16/05/2024 05:16 pm | BIOCON LIMITED: Q4 2024 Earnings Release |
16/05/2024 10:30 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
16/05/2024 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
15/05/2024 05:35 pm | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
15/05/2024 04:30 pm | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
15/05/2024 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
15/05/2024 01:35 am | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
15/05/2024 01:30 am | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VIRI Stock
- Calendar Virios Therapeutics, Inc.